Integrated Research (IRI) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
8 Jul, 2026Opening remarks and agenda
Meeting opened with acknowledgment of traditional land owners and confirmation of quorum, welcoming shareholders, brokers, analysts, and auditors both in person and online.
Chair Peter Lloyd and CEO Ian Lowe delivered addresses outlining the meeting's focus on financial performance, strategy, and governance.
Voting procedures and Q&A protocols explained, with all resolutions to be decided by poll for transparency.
Financial performance review
Total contract value (TCV) signed reached AUD 83.9 million, up 22% year-on-year, driven by strong growth in the Americas, while Europe saw a 25% decline.
Group revenues rose 19% to AUD 83.3 million, with statutory NPAT up 963% year-on-year, reversing a prior year loss.
Expenses reduced by 44% to AUD 58 million, leading to a net profit after tax of AUD 27.1 million.
Cash reserves increased 72% to AUD 31.9 million as of June 30, 2024, supporting future growth initiatives.
Proforma revenue was stable at AUD 74.8 million, with EBITDA margin at 22% and cash conversion rate at 97%.
Infrastructure and Transact products grew by 71% and 52% respectively, while Collaborate revenue declined by 11%.
Americas revenue grew 39%, Asia-Pacific declined 8%, and Europe dropped 28%.
Board and executive committee updates
Ian Lowe appointed as CEO and Managing Director effective October 1, 2024.
Board composition reduced from five to four non-executive directors, with new appointments including Mark Brayan, Michael Hitz, and Kate Greenhill.
Board underwent a refresh, appointing growth-oriented members to align with the new strategy.
Kate Greenhill's appointment as non-executive director to be ratified at the AGM.
Board and executive changes align with product-led growth strategy.
Latest events from Integrated Research
- Revenue fell 17% and EBITDA turned negative, but cash rose 27% to support product-led growth.IRI
Trading update24 Jul 2026 - Revenue and profit down, $4.8m credit loss, but cash up 8% to $43.6m for product-led growth.IRI
H1 20269 Jun 2026 - Steady pro forma revenue, but profits fell as investment and renewals softness weighed.IRI
H2 20259 Jun 2026 - New business revenue surged 76% as product-led growth offset renewal-driven declines.IRI
H1 20259 Jun 2026 - Revenue up 19%, NPAT up 193%, and cash up 72%, with FY25 focused on product-led growth.IRI
H2 20249 Jun 2026 - AI-driven innovation and hybrid pricing fuel growth and expand market reach.IRI
Investor Day 202624 Mar 2026 - Product-led growth and AI innovation drive future focus amid short-term profit decline.IRI
AGM 20253 Feb 2026 - New business TCV surges 87% as IR pivots to product-led growth despite overall revenue decline.IRI
Trading Update13 Jun 2025 - Strong FY24 results and CEO transition set the stage for product-led growth.IRI
Trading Update13 Jun 2025